Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents.

"Disclosure Professor Ayman Al-Hendy reports grants from the National Institutes of Health (NIH), during the conduct of the study; personal fees from AbbVie, personal fees from Bayer, personal fees from ObsEva, personal fees from Myovant Sciences, outside the submitted work; in addition, Professor Ayman Al-Hendy has a patent: Patent for novel diagnostics and therapeutics for uterine sarcoma pending to US Patent. The authors report no other conflicts of interest in this work."

"Disclosure: Professor Ayman Al-Hendy reports grants from the National Institutes of Health (NIH), during the conduct of the study; personal fees from AbbVie, personal fees from Bayer, personal fees from ObsEva, personal fees from Myovant Sciences, outside the submitted work; in addition, Professor Ayman Al-Hendy has a patent: Patent for novel diagnostics and therapeutics for uterine sarcoma pending to US Patent. The authors report no other conflicts of interest in this work."